Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2025-12-26 @ 10:36 AM
NCT ID:
NCT01721928
Eligibility Criteria:
Inclusion Criteria:
* ICU patients receiving prophylactic dalteparin
Exclusion Criteria:
* Age \< 18 years
* Intraocular bleeding
* Intracranial bleeding
* Acute spinal cord lesion
* Inherited coagulopathy
* Ongoing, uncontrolled bleeding
* Therapeutic anticoagulation
* Uncorrected coagulopathy
* Pregnancy or postpartum \< 6 weeks
* Participation in an interventional study
* RIFLE class E
* Consent not received
* ICU length of stay less than 48 hours
* DVT detected at first DUS examination
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01721928
Study Brief:
Protocol Section:
NCT01721928